Expected Budget Impact and Health Outcomes of Expanded Use of Vagus Nerve Stimulation Therapy for Drug-Resistant Epilepsy

Advances in Therapy
Molly F PurserJohn Forsey

Abstract

The objective was to estimate, from the perspective of a managed care organization in the United States, the budget impact and effect on health outcomes of expanded use of vagus nerve stimulation [VNS (VNS Therapy®)] among patients aged ≥ 12 years with drug-resistant epilepsy (DRE) with partial-onset seizures. An Excel model was developed to compare the costs of continued anti-epileptic drug (AED) treatment with the costs of VNS plus AED treatment. The number of people eligible for VNS was estimated using published prevalence data and an estimate of the percentage of eligible patients currently without VNS. Costs included VNS device, placement, programming, and battery changes; adverse events associated with VNS (cough, voice alteration, device removal resulting from surgical site infection); AEDs; and seizure-related costs affected by seizure frequency, which affects resource utilization (i.e., hospitalizations, emergency department visits, neurologist visits). To estimate the potential savings with VNS due to a reduction in seizure frequency, the budget impact model uses the results of an underlying Markov model to estimate seizure-related costs by seizure frequency. Transitions occurred among four health states, defined by n...Continue Reading

References

Apr 29, 1998·European Journal of Clinical Pharmacology·A MessoriG Zaccara
Feb 5, 2000·The New England Journal of Medicine·P Kwan, M J Brodie
Feb 18, 2005·Journal of Neurology, Neurosurgery, and Psychiatry·J JanszkyA Ebner
Nov 7, 2006·Epilepsy & Behavior : E&B·Allan L Bernstein, Terry Hess
Jun 28, 2008·Seizure : the Journal of the British Epilepsy Association·Raeburn Forbes
Aug 30, 2011·Epilepsy & Behavior : E&B·Sandra L HelmersEdward Faught
Sep 9, 2011·The New England Journal of Medicine·Patrick KwanMartin J Brodie
Jan 21, 2012·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Sandra L HelmersEdward Faught
Nov 3, 2012·Epilepsy Currents·Elinor Ben-Menachem
Feb 2, 2013·Acta Neurologica Scandinavica·B KristianL Forsgren
Jan 21, 2014·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Sean D SullivanWen-Yi Shau
Apr 4, 2015·The Cochrane Database of Systematic Reviews·Mariangela PanebiancoAnthony G Marson
Jul 29, 2015·Epilepsia·Charles E Begley, Tracy L Durgin

❮ Previous
Next ❯

Citations

Aug 28, 2020·International Journal of Environmental Research and Public Health·Carlo Efisio MarrasNelia Zamponi
Apr 28, 2020·Laryngoscope Investigative Otolaryngology·Helen L KochilasW Brent Tarver
Sep 18, 2020·Epilepsy & Behavior : E&B·Nallammai MuthiahTaylor J Abel
Jun 11, 2021·Frontiers in Neuroscience·Adam FitchettKirill Aristovich
Oct 30, 2020·Seizure : the Journal of the British Epilepsy Association·Dènahin Hinnoutondji ToffaDang Khoa Nguyen

❮ Previous
Next ❯

Software Mentioned

LivaNova
Cyberonics
Excel

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.